Sponsored content
A new name is now listed among the member companies of the official trade association for the European generic, biosimilar and value-added pharmaceutical industries.
Unlike many of the other member companies, though, CinnaGen does not hail from Europe or India, but rather Iran – and the biosimilar manufacturer is helping to put the country’s biopharmaceutical industry on the map with its rapid growth and ambition.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze